All Stories

  1. Governments must balance drug policies to reduce suffering

    Article • Journal of Pain & Palliative Care Pharmacotherapy, September 2018, Taylor & Francis

    Dr Katherine Pettus, Mrs Liliana De Lima, Dr Jim Cleary, Joan Marston

  2. Initial construct validity evidence of a virtual human application for competency assessment in breaking bad news to a cancer patient

    Article • Advances in Medical Education and Practice, July 2017, Dove Medical Press

    Timothy Guetterman, Dr Jim Cleary, Michael Fetters

  3. Opioid Availability and Palliative Care in Nepal: Influence of an International Pain Policy Fellowship

    Article • Journal of Pain and Symptom Management, January 2015, Elsevier

    Dr Jim Cleary

  4. Are Corticosteroids Effective in All Patients With Cancer-Related Pain?

    Article • Journal of Clinical Oncology, September 2014, American Society of Clinical Oncology (ASCO)

    Dr Jim Cleary

  5. An Examination of Global and Regional Opioid Consumption Trends 1980–2011

    Article • Journal of Pain & Palliative Care Pharmacotherapy, August 2014, Taylor & Francis

    Dr Jim Cleary

  6. Impact of Automatic Palliative Care Consultation for Hospitalized Patients with Advanced Cancer (S759)

    Article • Journal of Pain and Symptom Management, February 2014, Elsevier

    Dr Jim Cleary

  7. Determinants of Pain Severity Changes in Ambulatory Patients With Cancer: An Analysis From Eastern Cooperative Oncology Group Trial E2Z02

    Article • Journal of Clinical Oncology, December 2013, American Society of Clinical Oncology (ASCO)

    Dr Jim Cleary

  8. Next steps in access and availability of opioids for the treatment of cancer pain: reaching the tipping point?

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  9. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  10. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI)

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  11. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: a report from the Global Opioid Policy Initiative (GOPI)

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  12. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI)

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  13. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI)

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  14. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology

    Article • Annals of Oncology, November 2013, Oxford University Press (OUP)

    Dr Jim Cleary

  15. Examining Influences on the Availability of and Access to Opioids for Pain Management and Palliative Care

    Article • Journal of Pain & Palliative Care Pharmacotherapy, July 2013, Taylor & Francis

    Dr Jim Cleary

  16. Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional, and Country Levels

    Article • Journal of Pain and Symptom Management, April 2013, Elsevier

    Dr Jim Cleary

  17. Multivariate analysis of countries’ government and health-care system influences on opioid availability for cancer pain relief and palliative care: More than a function of human development

    Article • Palliative Medicine, October 2012, SAGE Publications

    Dr Jim Cleary

  18. Letter to the Editor

    Article • Journal of Pain & Palliative Care Pharmacotherapy, May 2012, Taylor & Francis

    Dr Jim Cleary, Dr Willem Scholten

  19. Ensuring Patient Access to Essential Medicines While Minimizing Harmful Use: A Revised World Health Organization Tool to Improve National Drug Control Policy

    Article • Journal of Pain & Palliative Care Pharmacotherapy, August 2011, Taylor & Francis

    Dr Jim Cleary

  20. Building Effective Hospice and Palliative Care Teams (P4)

    Article • Journal of Pain and Symptom Management, February 2010, Elsevier

    Dr Jim Cleary, Dr Jim Cleary

  21. 752 IMPROVING THE AVAILABILITY AND ACCESSIBILITY OF OPIOID ANALGESICS IN ARMENIA AND GEORGIA

    Article • European Journal of Pain, September 2009, Wiley

    Dr Jim Cleary

  22. Epidemiology of Cancer

    Article • January 2009, Elsevier

    Dr Jim Cleary, Dr Jim Cleary

  23. The Pharmacologic Management of Cancer Pain

    Article • Journal of Palliative Medicine, December 2007, Mary Ann Liebert Inc

    Dr Jim Cleary

  24. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial

    Article • Palliative Medicine, December 2007, SAGE Publications

    Dr Jim Cleary

  25. (996)

    Article • Journal of Pain, April 2006, Elsevier

    Dr Jim Cleary

  26. Incident pain

    Article • Palliative Medicine, January 2005, SAGE Publications

    Dr Jim Cleary, Dr Jim Cleary

  27. Assessment and management of GI symptoms

    Article • Journal of Pain and Symptom Management, October 2003, Elsevier

    Dr Jim Cleary, Dr Jim Cleary

  28. Treatment of pain crisis at end of life from severe lower extremity venous outflow obstruction with hyperalgesia and allodynia

    Article • Journal of Pain, June 2002, Elsevier

    Dr Jim Cleary

  29. Responding to SUPPORT: An Academic Medical Center Examines Its End-of-Life Care Practices

    Article • Journal of Pain and Symptom Management, February 2001, Elsevier

    Dr Jim Cleary

  30. Incidence and Characteristics of Naloxone Administration in Medical Oncology Patients with Cancer Pain

    Article • Journal of Pharmaceutical Care in Pain & Symptom Control, August 2000, The Haworth Press

    Dr Jim Cleary

  31. Oral Transmucosal Fentanyl Citrate: Randomized, Double-Blinded, Placebo-Controlled Trial for Treatment of Breakthrough Pain in Cancer Patients

    Article • JNCI Journal of the National Cancer Institute, April 1998, Oxford University Press (OUP)

    Dr Jim Cleary

  32. Development of a new fatigue assessment tool in cancer patients

    Article • Journal of Pain and Symptom Management, April 1998, Elsevier

    Dr Jim Cleary

  33. Palliative medicine in the elderly

    Article • Cancer, October 1997, Wiley

    Dr Jim Cleary, Dr Jim Cleary

  34. Palliative medicine in the elderly

    Article • Cancer, October 1997, Wiley

    Dr Jim Cleary

  35. Palliative Medicine in Lung Cancer

    Article • January 1997, Karger Publishers

    Dr Jim Cleary

  36. Plasma concentrations and renal clearances of morphine-6- and morphine-3-glucuronide in cancer patients receiving morphine

    Article • Pain, January 1990, Wolters Kluwer Health

    Dr Jim Cleary